Kay Elizabeth Davies
Co-Founder, Chairman of Scientific Advisory Board and Scientific AdvisorProf. Kay Elizabeth Davies is Honorary Director of UCB SA from 2026. Prof. Davies is a Co-Founder, Chairman of Scientific Advisory Board and Scientific Advisor of Summit Therapeutics Inc. (Formally known as Summit Therapeutics plc). Prof. Davies has been an Independent Non-Executive Director of The Biotech Growth Trust PLC since March 15, 2012. She has been Independent Non-Executive Director at Oxford Biomedica plc since March 1, 2021 and is its Senior Independent Director since March 27, 2023 and also serves as its Chair of Innovation & Technology Excellence Board since June 2025. Prof. Davies served as Deputy Chair of the Wellcome Trust between 2013 and 2017. Prof. Davies is Founder at Oxstem Ltd. Prof. Davies is also a Fellow of the Royal Society (2003) and a Member of the European Molecular Biology Organization. Prof. Davies had been an Independent Director of UCB SA since April 24, 2014 until April 30, 2026. She serves as a Director of Biotech Growth Trust. Prof. Davies serves as a Member of Scientific & Clinical advisory board at BioMarin Nederland B.V. She has been a Member of Board of Governors at The Wellcome Trust Limited since 2008. Prof. Davies serves as is the Dr. Lee's Professor of Anatomy, Head of the Department of Human Anatomy and Genetics, Honorary Director of MRC Functional Genetics Unit, University of Oxford. Her research interests lie in the molecular analysis of human genetic disease, particularly Duchenne Muscular Dystrophy, spinal muscular atrophy and ataxias. She was Governor of Wellcome Trust Finance plc. She is also Co-director of the Oxford Centre of Gene Function which she co-founded in 1999 as a new multidisciplinary institute bringing together genetics, physiology and populations genetics. She has won numerous awards for her work. Prof. Davies established the first physical map of the DMD gene and discovered the closely related gene called utrophin that forms a target for treating the disease. She has considerable experience of biotechnology companies as a conduit for translating the results of experimental science into new therapeutics and diagnostics. She is a founding fellow of the UK Academy of Medical Sciences and was elected a Fellow of the Royal Society in 2003. She was made Dame Commander of the British Empire for services to science in 2008, Commander of the British Empire (CBE) since 1996 and Fellow of the Academy of Medical Sciences (FMedSci) since 1998. She is Professor of Genetics and Co-Director (and Founder Member) of MDUK Oxford Neuromuscular Centre at the University of Oxford. She holds her BA in Chemistry in 1973 and D.Phil. in Biochemistry in 1976 from the University of Oxford.
Positions
- Company NameSummit Therapeutics Inc.Stock CodeSMMTPositionCo-Founder, Chairman of Scientific Advisory Board and Scientific Advisor
